Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Summit Therapeutics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 96 | 91 | −5 |
| Shares | 34.9M | 32.3M | −2.62M (−7.5%) |
| Value | $87.6M | $60.4M | −$27.2M (−31.1%) |
New holders (8)
Institutions that held Summit Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 57,800 | $108.1K | 0.00% |
| Rathbone Brothers plc | 30,317 | $56.7K | 0.00% |
| AQR Capital Management LLC | 19,225 | $36.0K | 0.00% |
| Federated Hermes, Inc. | 17,877 | $33.4K | 0.00% |
| Three Seasons Wealth, LLC | 12,869 | $24.1K | 0.02% |
| Russell Investments Group, Ltd. | 2,517 | $4.71K | 0.00% |
| Allworth Financial LP | 64 | $120 | 0.00% |
| Covestor Ltd | 71 | $0 | 0.00% |
Sold out (13)
Institutions that held Summit Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 116,723 | $293.0K |
| Virtu Financial LLC | 43,563 | $109.0K |
| Tudor Investment Corp Et Al | 32,103 | $80.6K |
| ExodusPoint Capital Management, LP | 25,775 | $65.0K |
| Evoke Wealth, LLC | 25,218 | $63.3K |
| Simplex Trading, LLC | 25,114 | $63.0K |
| Jane Street Group, LLC | 21,399 | $53.7K |
| Creative Planning | 16,430 | $41.2K |
| Snowden Capital Advisors LLC | 12,500 | $31.4K |
| Balyasny Asset Management LLC | 10,157 | $25.5K |
| Harbour Investments, Inc. | 300 | $753 |
| Quadrant Capital Group LLC | 177 | $445 |
| 25 LLC | 200 | $440 |